Cancer remains a major global health challenge, requiring continued advances in research and clinical practice. II ANNUAL CONFERENCE ON CANCER RESEARCH AND THERAPEUTICS (ACRT 2027) brings together researchers, clinician-scientists, healthcare professionals, and industry experts to discuss developments across cancer biology, tumor immunology, precision oncology, therapeutic discovery, and translational medicine. ACRT 2027 will foster scientific exchange across the entire oncology research spectrum — from fundamental mechanisms of cancer biology to emerging therapeutic strategies, precision oncology, and clinical translation.
Set in the Great Baltimore, ranks second for science and technology and holding more than 60 federal agencies and research labs are within 30 miles of Baltimore. The conference offers an exceptional environment for collaboration, innovation, networking, and partnership development between academia, industry, and healthcare sectors.
Join global leaders driving the next generation of cancer discovery and therapeutic innovation.
Note for the organizers: placeholder — drop your ACRT 2026 recap in as a self-hosted <video> or a YouTube/Vimeo <iframe>; both patterns are commented below this section in index.php.
ACRT held its first edition in Boston and Cambridge, March 25–27, 2026, across the same eleven scientific tracks returning for 2027. ACRT 2027 builds on that foundation in Baltimore.
Program 2026
Director, Center for Stem Cell and Translational Immunotherapy; engineers gene-edited cell therapies for brain tumors.
Peter C. Doherty Chair of Immunology; a leading authority on apoptosis and cell death in cancer.
Studies the tumor stroma and FAP; pioneered stromal-targeted CAR T approaches for solid tumors.
Hilton BWI Hotel
1739 West Nursery Road, Linthicum Heights MD 21090
